agilon health (NYSE:AGL) Announces Quarterly Earnings Results

agilon health (NYSE:AGLGet Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.07), Zacks reports. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%.

agilon health Trading Up 1.8 %

AGL stock traded up $0.07 during midday trading on Tuesday, hitting $3.71. The stock had a trading volume of 6,725,137 shares, compared to its average volume of 5,298,555. agilon health has a 12-month low of $1.50 and a 12-month high of $7.73. The company’s 50-day moving average price is $2.85 and its 200 day moving average price is $3.05. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a market cap of $1.53 billion, a PE ratio of -3.94 and a beta of 0.66.

Insider Activity at agilon health

In related news, Director Karen Mcloughlin bought 25,000 shares of the stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the acquisition, the director now owns 73,166 shares in the company, valued at $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director John William Wulf purchased 45,000 shares of the firm’s stock in a transaction on Thursday, December 5th. The stock was bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares in the company, valued at $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 77,500 shares of company stock worth $169,600. 3.20% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on AGL shares. Macquarie started coverage on agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 price target on the stock. Needham & Company LLC started coverage on shares of agilon health in a research report on Friday, January 10th. They set a “hold” rating on the stock. William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and increased their price target for the stock from $1.75 to $2.25 in a research note on Friday, January 10th. Finally, Barclays dropped their price objective on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $4.03.

Read Our Latest Stock Analysis on agilon health

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Earnings History for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.